Efficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases.
Clinical trial NCT05872347 · RECRUITING
Trial details
- NCT number
- NCT05872347
- Sponsor
- Shanghai Pharmaceuticals Holding Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-19
- Primary completion
- 2026-12-31
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.